Insilico raises $255M to advance human trials and AI drug discovery platform
Longevity Technology - 22-Jun-2021New collab with Teva Pharmaceuticals to identify drug targets for various diseases
Join the club for FREE to access the whole archive and other member benefits.
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
31-Aug-2021 to 03-Sep-2021
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a socioeconomic challenge to societies worldwide, and necessitates new sweeping interventions for age-associated diseases. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target aging process ensuring everyone lives a healthier and longer life. Welcome to the 8th Aging Research and Drug Discovery Meeting.
Visit website: http://www.agingpharma.org/speakers
See also: University of Copenhagen - Public research university
Details last updated 24-Apr-2021
Interested in more events? View the club's event calendar.
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
AI to track the rate of ageing at the molecular, cellular, tissue, organ, system, physiological, and psychological levels
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Developing and marketing, unmatched in its reliability & precision, instrumentation for metabolic and behavior measurement.
New collab with Teva Pharmaceuticals to identify drug targets for various diseases